C-reactive protein in acute pulmonary embolism

Journal of Investigative Medicine

Volumn 59, Issue 1, 2011, Pages 8-14

  Abul, Yasin ^a   Karakurt, Sait ^b   Ozben, Beste ^b   Toprak, Ahmet ^c   Celikel, Turgay ^a  

^a MINISTRY OF HEALTH   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

^c Tulane Center for Cardiovascular Health   (United States)

Author keywords

C reactive protein; Inflammation; N terminal proB type natriuretic peptide; Prognosis; Pulmonary embolism; Right ventricular dysfunction; Survival

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; TROPONIN T; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; ARTICLE; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HEART RIGHT VENTRICLE FUNCTION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTIVE VALUE; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TRANSTHORACIC ECHOCARDIOGRAPHY; ANTICOAGULANT THERAPY; FOLLOW UP; HEART VENTRICLE FUNCTION; MIDDLE AGED; MORTALITY RATE; PROTEIN BLOOD LEVEL;

EID: 78651502935     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.2310/JIM.0b013e31820017f2     Document Type: Article

References (39)

1. Stenmark KR, Mecham RP. Cellular and molecular mechanisms of pulmonary vascular remodeling. Annu Rev Physiol. 1997;59:89-144.
2. Jeffery TK, Wanstall JC. Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension. Pharmacol Ther. 2001;92:1-20.
3. Goldhaber SZ, Haire WD, Feldstein ML, et al. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet. 1993;341:507-511.
4. Kasper W, Konstantinides S, Geibel A, et al. Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism. Heart. 1997;77:346-349.
5. Lualdi JC, Goldhaber SZ. Right ventricular dysfunction after acute pulmonary embolism: pathophysiologic factors, detection, and therapeutic implications. Am Heart J. 1995;130:1276-1282.
6. Becattini C, Vedovati MC, Agnelli G. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation. 2007;116:427-433.
7. Binder L, Pieske B, Olschewski M, et al. N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism. Circulation. 2005;112:1573-1579.
8. Watts JA, Zagorski J, Gellar MA, et al. Cardiac inflammation contributes to right ventricular dysfunction following experimental pulmonary embolism in rats. J Mol Cell Cardiol. 2006;41:296-307.
9. Olechnicki M, Kasprzak K, Goch A. [Growth differentiation factor 15Va new marker in heart diseases]. Pol Merkur Lekarski. 2010;28:470-472.
10. Lankeit M, Kempf T, Dellas C, et al. Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism. Am J Respir Crit Care Med. 2008;177:1018-1025.
11. Kaczyñska A, Pelsers MM, Bochowicz A, et al. Plasma heart-type fatty acid binding protein is superior to troponin and myoglobin for rapid risk stratification in acute pulmonary embolism. Clin Chim Acta. 2006;371:117-123.
12. Ridker PM. C-reactive protein and risks of future myocardial infarction and thrombotic stroke. Eur Heart J. 1998;19:1-3.
13. Mitchell AM, Nordenholz KE, Kline JA. Tandem measurement of D-dimer and myeloperoxidase or C-reactive protein to effectively screen for pulmonary embolism in the emergency department. Acad Emerg Med. 2008;15:800-805.
14. Barnes DM, Wakefield TW, Rectenwald JE. Novel biomarkers associated with deep venous thrombosis: a comprehensive review. Biomark Insights. 2008;3:93-100.
15. Ridker PM, Buring JE, Shih J, et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 1998;98:731-733.
16. Verma S, Badiwala MV, Weisel RD, et al. C-reactive protein activates the nuclear factor-kappaB signal transduction pathway in saphenous vein endothelial cells: implications for atherosclerosis and restenosis. J Thorac Cardiovasc Surg. 2003;126:1886-1891.
17. Verma S, Yeh ET. C-reactive protein and atherothrombosis-beyond a biomarker: an actual partaker of lesion formation. Am J Physiol Regul Integr Comp Physiol. 2003;285: R1253-R1256.
18. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000;102:2165-2168.
19. Goldhaber SZ. The current role of thrombolytic therapy for pulmonary embolism. Semin Vasc Surg. 2000;13:217-220.
20. Cannon CP, Goldhaber SZ. Cardiovascular risk stratification of pulmonary embolism. Am J Cardiol. 1996;78:1149-1151.
21. Kasper W, Konstantinides S, Geibel A, et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol. 1997;30:1165-1171.
22. Kucher N, Rossi E, De Rosa M, et al. Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher. Arch Intern Med. 2005;165:1777-1781.
23. van der Meer RW, Pattynama PM, van Strijen MJ, et al. Right ventricular dysfunction and pulmonary obstruction index at helical CT: prediction of clinical outcome during 3-month follow-up in patients with acute pulmonary embolism. Radiology. 2005;235:798-803.
24. Jiménez D, Uresandi F, Otero R, et al. Troponin-based risk stratification of patients with acute nonmassive pulmonary embolism: systematic review and metaanalysis. Chest. 2009;136:974-982.
25. Grifoni S, Olivotto I, Cecchini P, et al. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation. 2000;101:2817-2822.
26. Konstantinides S, Geibel A, Olschewski M, et al. Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation. 2002;106:1263-1268.
27. ten Wolde M, Tulevski II, Mulder JW, et al. Brain natriuretic peptide as a predictor of adverse outcome in patients with pulmonary embolism. Circulation. 2003;107:2082-2084.
28. Lim SY, Jeong MH, Bae EH, et al. Predictive factors of major adverse cardiac events in acute myocardial infarction patients complicated by cardiogenic shock undergoing primary percutaneous coronary intervention. Circ J. 2005;69:154-158.
29. Biasucci LM, Vitelli A, Liuzzo G, et al. Elevated levels of interleukin-6 in unstable angina. Circulation. 1996;94:874-877.
30. Chalmers JD, Singanayagam A, Hill AT. C-reactive protein is an independent predictor of severity in community-acquired pneumonia. Am J Med. 2008;121:219-225.
31. Kyrle PA, Minar E, Hirschl M, et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med. 2000;343:457-462.
32. Marchena Yglesias PJ, Nieto Rodríguez JA, Serrano Martíinez S, et al. Acute-phase reactants and markers of inflammation in venous thromboembolic disease: correlation with clinical and evolution parameters. An Med Intern. 2006;23:105-110.
33. Topal E, Ozdemir R, Aksoy Y, et al. Tissue Doppler velocities of the right and left ventricles and their association with C-reactive protein and homocysteine levels in Behcet's disease. Am J Cardiol. 2005;96:1739-1742.
34. Poredos P, Jezovnik MK. The role of inflammation in venous thromboembolism and the link between arterial and venous thrombosis. Int Angiol. 2007;26:306-311.
35. Fox AE, Kahn RS. The relationship between inflammation and venous thrombosis. A systematic review of clinical studies. Thromb Haemost. 2005;94:362-365.
36. Thomas EA, Cobby MJ, Rhys DE, et al. Liquid crystal thermography and C reactive protein in the detection of deep venous thrombosis. BMJ. 1989;299:951-952.
37. Wong NA, Laitt RD, Goddard PR, et al. Serum C reactive protein does not reliably exclude lower limb deep venous thrombosis. Thromb Haemost. 1996;76:816-817.
38. Maskell NA, Butland RJ. A normal serum CRP measurement does not exclude deep vein thrombosis. Thromb Haemost. 2001;86:1582-1583.
39. Bucek RA, Reiter M, Quehenberger P, et al. C-reactive protein in the diagnosis of deep vein thrombosis. Br J Haematol. 2002;119:385-389.